Evidence Investigator
Adaptable, Efficient & Comprehensive
Why Choose the Evidence Investigator?
- World’s first platform to consolidate both immunoassay and molecular diagnostics.
- Multiplexing capabilities of Biochip Technology supports accurate test results with CVs typically <10%.
- The Evidence Investigator has a throughput of 2376 tests per hour with up to 44 analytes screened per biochip.
- Reduced sample volume of 7-25uL is required, leaving more sample remaining for confirmatory testing.
- The Evidence Investigator can store up to 20,000 sample results and up to 500,000 sample test results.
- Multiplex testing delivers a fast and cost effective solution compared to traditional methods.
The Evidence Investigator is the no.1 choice for research, clinical, forensic, molecular, and veterinary testing. Renowned for its versatility, robustness and effective reporting methods, this compact, semi-automated benchtop platform offers efficient and comprehensive testing without compromising on accuracy. It is the perfect fit for medium throughput laboratories seeking maximum use of benchspace.
The Evidence Investigator is able to consolidate both immunoassay and molecular testing offering the most comprehensive test menu on the market, achieved through protein and DNA based biochips improving laboratory efficiency and reducing costs.
The Evidence Investigator
Meet the Evidence Investigator
The Evidence Investigator improves laboratory efficiency and helps to reduce cost by consolidating immunoassay and molecular diagnostics.
Using chemiluminescent as a measurement principle, the Evidence Investigator consistently delivers accurate results.
All data is analysed on-board, removing issues related to human error and result manipulation.
Meet the Biochip Carrier
Each biochip can have up to 49 Discrete Test Regions (DTR) allowing up to 44 tests to be carried out simultaneously.
A maximum of 6 biochips can be added to the one Biochip carrier on the Evidence Investigator.
A smaller sample volume is required due to multiplexing capabilities.
Using protein and DNA based biochips provides the user the ability to consolidate tests.
Evidence Investigator Test Menu
| SARS-COV-2 ARRAY | |||
| Pathogens | |||
| SARS-CoV-2 (COVID-19) | Sarbecovirus (SARS, SARS Like, SARS-CoV-2) | ||
| EXTENDED CORONAVIRUS ARRAY | |||
| Pathogens | |||
| SARS-CoV-2 (COVID-19) | Enterovirus A/B/C | Influenza A | Influenza B |
| Coronavirus 229E/NL63 | Middle East Respiratory Syndrome Coronavirus (MERS-CoV) | Sarbecovirus (SARS, SARS like, SARS-CoV-2) | Adenovirus A/B/C/D/E |
| Coronavirus OC43/HKUI | Rhinovirus A/B | ||
| SARS-CoV-2 IgG (RBD & NP) ARRAY | |||
| Antigens | |||
| Nucleocapsid Protein (NP) | Spike Receptor Binding Domain (RBD) |
| Acute Kidney Injury | |||
| Clusterin | Cystatin C | Kidney Injury Molecule-I | Lipocalin |
| Adhesion Molecules | |||
| E-Selectin | Intercellular Adhesion Molecule-I | L-selectin | P-selectin |
| Vascular Cell Adhesion Molecule-I | |||
| Anaemia | |||
| Ferritin | |||
| Alzheimers Risk | |||
| ApoE4 | Pan ApoE | ||
| Cerebral | |||
| D-Dimer | Neuron Specific Enolase | Neutrophil Gelatinase-Associated Lipocalin | Soluble Tumour Necrosis Factor Receptor I |
| Chronic Kidney Disease | |||
| C3a Des Arg | C-Reactive Protein | Cystatin C | D-Dimer |
| Epidermal Growth Factor | Fatty Acid-Binding Protein I | Interlukin-8 | Macrophage Inflammatory Protein-1α |
| Neutrophil Gelatinase-Associated Lipocalin | Soluble Tumour Necrosis Factor Receptor I | Soluble Tumour Necrosis Factor Receptor II | |
| Covid-19 | |||
| SARS-CoV-2 Antigen | Receptor Binding Domain | Nucleocapsid | |
| Cytokines | |||
| Granulocyte-Macrophage Colony Stimulating Factor | Interleukin-1α | Interleukin-1ϐ | Interleukin - 2 |
| Interleukin - 3 | Interleukin - 4 | Interleukin - 5 | Interleukin - 6 |
| Interleukin - 7 | Interleukin - 8 | Interleukin - 10 | Interleukin - 12p70 |
| Interleukin - 13 | Interleukin - 15 | Interleukin - 23 | Interferon Gamma |
| Human EGF | Monocyte Chemotactic Protein | Macrophage Inflammatory Protein-1α | Matrix Metalloproteinase-9 |
| Soluble IL-2 Receptor α | Soluble IL-6 Receptor | Soluble Tumour Necrosis Factor Receptor I | Soluble Tumour Necrosis Factor Receptor II |
| Tumour Necrosis Factor Alpha | Vascular Endothelial Growth Factor |
| Epidermal Growth Factor (EGF) | |||
| Amphiregulin (AREG) | Herapin-Binding EGF-like Growth Factor (HBEGF) | Transforming Growth Factor - Alpha (TGF-α) | |
| Gastrointestinal | |||
| Gastrin 17 | Helicobacter Pylori | Pepsinogen I | Pepsinogen II |
| Immunodeficiency | |||
| Interleukin - 17A | Interleukin - 17F | Interleukin - 22 | Interleukin - 17 |
| Metabolic | |||
| Ferritin | Interleukin - 6 | Insulin | Adiponectin |
| C-Reactive Protein | Cystatin C | Leptin | Parathyroid Hormone |
| Plasminogen Activator Inhibitor-I | PTH | Resistin | Tumour Necrosis Factor α |
| Pancreatic Cancer | |||
| Cancer Antigen 19-9 - CA19-9 | Carcinoembryonic Antigen | Alpha-I-Acid Glycoprotein | |
| Stroke | |||
| Brain-Derived Neurotrophic Factor - BDNF | D-Dimer | Glial Fibrillary Acidic Protein - GFAP | Glutathione S - Transferase Pi - GSTPi |
| Heart-Type Fatty Acid-Binding Protein - FABP3 | Interleukin-6 - IL-6 | Nucleoside Diphosphate Kinase - NDKA | Neuron Specific Enolase - NSE |
| Parkinson Protein 7 - PARK-7 | Soluble Tumour Necrosis Factor Receptor I - sTNFRI |
| Thyroid | |||
| Anti-Thyroglobulin (TgAb) | Anti-Thyroid Peroxidase Antibody (TPOAb) | Thyroxine Binding Globulin (TBG) | Total Thyroxine (TT4) |
| Total Tri-Iodothyronine (TT3) | |||
| Tissue Damage | |||
| Adipose Fatty Acid Binding Protein - FABP4 | Brain Fatty Acid Binding Protein - FABP7 | Epidermal Fatty Acid Binding Protein - FABP5 | Heart-Type Fatty Acid-Binding Protein - FABP3 |
| Ileal Fatty Acid Binding Protein - FABP6 | Liver Fatty Acid Binding Protein-I - FABPI | Testis Fatty Acid Binding Protein - FABP9 |
| CARDIAC RISK PREDICTION | |||
| Target | SNP | Target | SNP |
| MIA3* | rs17465637 | LPA* | rs3798220 |
| 9p21 | rs10757274 | LPA* | rs10455872 |
| DAB2IP | rs7025486 | MRAS* | rs9818870 |
| CXCL12 | rs1746048 | LPL* | rs328 |
| ACE | rs4341 | LPL | rs1801177 |
| NOS3 | rs1799983 | SORT1*+ | rs646776+ |
| APOA5 | rs662799 | PCSK9 | rs11591147 |
| SMAD3 | rs17228212 | APOE* | rs429358 |
| APOB* | rs1042031 | APOE* | rs7412 |
| CETP | rs708272 | ||
| CHRONIC LUNG DISEASE (CLD) ARRAY | |||
| Viral | |||
| Adenovirus | Metapneumovirus | Respiratory syncytial virus A | Respiratory syncytial virus B |
| Rhinovirus A/B/C | Influenza virus A | Influenza virus B | |
| Bacterial | |||
| Achromobacter xylosoxidans | Bordetella pertussis | Burkholderia cepacia complex (21spp) | Burkholderia cenocepacia |
| Chlamydia pneumoniae | Haemophilus influenza | Moraxella catarrhalis | Mycoplasma pneumoniae |
| Non-tuberculous mycobacterium (15 spp) | Mycobacterium avium complex (4 spp) | Pandoraea species (5 spp) | Prevotella species (16 spp) |
| Pseudomonas aeruginosa | Staphylococcus aureus | Stenotrophomonas maltophilia | Streptococcus pneumoniae (21 spp) |
| Streptococcus species (19 spp) | Veillonella species (3 spp) | ||
| Fungal | |||
| Aspergillus fumigatus | Candida albicans | Exophialia dermatitidis | Scedosporium species (7 spp) |
| Antibiotic Resistance Markers | |||
| mecA (incl MRSA) |
| FAMILIAL HYPERCHOLESTEROLEMIA | |||
| LDLR 38 mutations | APOB 1 mutation | PCSK9 1 mutation | |
| APOB | PCSK9 | ||
| Mutation | Protein | Mutation | Protein |
| c.10580G>A | p.(Arg3527Gln) | c.1120G>T | p.(Asp374Tyr) |
| LDR | |||
| Mutation | Protein | Mutation | Protein |
| c.2292delA | p.(Ile764Metfs*2) | c.1187-10G>A | p.(=) |
| c.1444G>A | p.(Asp482Asn) | c.1048C>T | p.(Arg350*) |
| c.551G>A | p.(Cys184Tyr) | c.118delA | p.(Ile40Serfs*166) |
| c.1845+11C>G | p.(=) | c.1168A>T | p.(Lys390*) |
| c.693C>A | p.(Cys231*) | c.232C>T | p.(Arg78Cys) |
| c.933delA | p.(Glu312Serfs*58) | c.1587-1G>A | p.(=) |
| c.301G>A | p.(Glu101Lys) | c.1706-10G>A | p.(=) |
| c.313+1G>A | p.(=) | c.1796T>C | p.(Leu599Ser) |
| c.1706-1G>A | p.(=) | c.1436T>C | p.(Leu479Pro) |
| c.1706-1G>A | p.(Cys677Arg) | c.1474G>A | p.(Asp492Asn) |
| c.2029T>C | p.(Pro685Leu) | c.501C>A | p.(Cys167*) |
| c.2054C>T | p.(Trp483Arg) | c.662A>G | p.(Asp221Giy) |
| c.1447T>C | p.(Gly478Arg) | c.682G>T | p.(Glu228*) |
| c.1447T>C | p.(Asp72Thrfs*134) | c.1150C>T | p.(Gln384*) |
| c.214delG | p.(Trp87Gly) | c.938G>A | p.(Cys313Tyr) |
| c.259T>G | p.(Arg633Cys) | c.136T>G | p.(Cys46Gly) |
| c.1897C>T | p.(Asp227Glu) | c.2042G>C | p.(Cys681Ser) |
| c.681C>G | p.(Asn688Glnfs*29) | c.1618G>A | p.(Ala540Thr) |
| c.1285G>A | p.(Val429Met) | c.680_681delAC | p.(Asp227Glyfs*12) |
| KRAS, BRAF, PIK3CA ARRAY | |||
| KRAS Gene Targets | |||
| G12A | G12R | G12D | G12C |
| G12S | G12V | G13D | G13C |
| G13R | Q61K | Q61L | Q61R |
| Q61H(1) | Q61H(2) | A146T | A146P |
| BRAF Gene Targets | |||
| V600EG12R | |||
| PIK3CA Gene Targets | |||
| E542K | E545K | H1047R | |
| RESPIRATORY MULTIPLEX ARRAY II | |||
| Viral | |||
| Influenza A | Influenza B | Adenovirus A/B/C/D/E | Bocavirus 1/2/3 |
| Coronavirus 229E/NL63 | Coronavirus OC43/HKUI | Enterovirus A/B/C | Metapneumovirus |
| Parainfluenza virus 1 | Parainfluenza virus 2 | Parainfluenza virus 3 | Parainfluenza virus 4 |
| Respiratory syncytial virus A/B | Rhinovirus A/B/C | ||
| Bacterial | |||
| Legionella pneumophila | Bordetella pertussis | Chlamydophila pneumoniae | Haemophilus influenzae |
| Moraxella catarrhalis | Mycoplasma pneumoniae | Streptococcus pneumoniae |
| SEXUALLY TRANSMITTED INFECTION (STI) ARRAY | |||
| Pathogens | |||
| Chlamydia trachomatis (CT) | Neisseria gonorrhoea (NG) | Trichomonas vanginalis (TV) | Mycoplasma genitalium (MG) |
| Treponema pallidum (Syphilis) (TP) | Herpes simplex virus 1 (HSV-1) | Herpes simplex virus 2 (HSV-2) | Haemophilus ducreyi (HD) |
| Mycoplasma hominis (MH) | Ureaplasma urealyticum (UU) | ||
| URINARY TRACT INFECTION (UTI) ARRAY | |||
| Bacterial | |||
| Acinetobacter baumannii | Citrobacter freundii | Citrobacter koseri | Klebsiella aerogenes |
| Enterobacter cloacae | Enterococcus faecalis | Enterococcus faecium | Escherichia coli |
| Klebsiella oxytoca | Klebsiella pneumoniae | Morganella morganii | Proteus spp. |
| Pseudomonas aeruginosa | Providencia rettgeri | Providencia stuartii | Serratia marcescens |
| Staphylococcus aureus | Staphylococcus epidermidis | Staphylococcus saprophyticus | Streptococcus agalactiae (GBS) |
| Fungal | |||
| Candida albicans | |||
| Antibiotic Resistance Markers | |||
| mecA (incl MRSA) | Trimethoprim Resistance 1 | Trimethoprim Resistance 2 | Trimethoprim Resistance 3 |
| S mecA (incl MRSA) | Trimethoprim Resistance 4 | Trimethoprim Resistance 5 | Van A (Vancomycin Resistance A) |
| Van B (Vancomycin Resistance B) |
| DoA I+ | |||
| Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) | Benzodiazepines II (Lorazepam) |
| Buprenorphine | Benzoylecgonine (Cocaine Metabolite) | Cannabinoids (THC) | Creatinine (Urine Only) |
| Methadone | Methamphetamine | MDMA | Opiate |
| Phencyclidine (PCP) | Tricyclic Antidepressants (TCA) | ||
| DoA ULTRA | |||
| Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) | Benzodiazepines II (Lorazepam) |
| Benzodiazepines III (Clonazepam) | Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Dextromethorphan | Fentanyl | Generic Opioids | Meprobamate |
| Methadone | Methamphetamine | Opiates | Oxycodone I |
| Oxycodone II | Phencyclidine (PCP) | Tramadol | Tricyclic Antidepressants (TCA) |
| Zolpidem | |||
| DoA Hair Array | |||
| Amphetamine | Benzodiazepine | Cannabinoids (THC) | Benzoylecgonine (Cocaine Metabolite) |
| Hydrocodone | Ketamine | Methamphetamine | Opiate |
| Oxymorphone | Phencyclidine (PCP) | ||
| DoA MultiSTAT - Blood | |||
| α-PVP (Flakka) | Amphetamine | Barbiturates | Benzodiazepines |
| Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) | Ethyl Glucuronide (EtG) |
| Fentanyl | Methadone | Methamphetamine | Opiate |
| Oxycodone | Phencyclidine (PCP) | Pregabalin | Synthetic Cannabinoids (AB-CHMINACA) |
| Synthetic Cannabinoids (AB-PINACA) | Tramadol | Tricyclic Antidepressants (TCA) | 6-MAM |
| DoA MultiSTAT - Oral Fluid | |||
| α-PVP (Flakka) | Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) |
| Benzodiazepines II (Lorazepam) | Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Fentanyl | LSD | Methadone | Methamphetamine |
| Opiate | Oxycodone | Phencyclidine (PCP) | Synthetic Cannabinoids (JWH-018) |
| Synthetic Cannabinoids (UR-144/XLR-11) | Tramadol | 6-MAM | Ketamine |
| DoA MultiSTAT - Urine I | |||
| α-PVP (Flakka) | Amphetamine | Barbiturates | Benzodiazepines I (Oxazepam) |
| Benzodiazepines II (Lorazepam) | Benzoylecgonine (Cocaine Metabolite) | Buprenorphine | Cannabinoids (THC) |
| Creatinine | Ethyl Glucuronide (EtG) | Fentanyl | Methadone |
| Methamphetamine | Opiate | Oxycodone | Synthetic Cannabinoids (JWH-018) |
| Synthetic Cannabinoids (UR-144/XLR-11) | Synthetic Cannabinoids (AB-PINACA) | Tramadol | Tricyclic Antidepressants (TCA) |
| 6-MAM | |||
| DoA MultiSTAT - Urine II | |||
| Alpha-PVP | AB-PINACA | AB-CHMINACA | Amphetamine |
| Barbiturate | Benzodiazepine | BZG | Creatinine |
| Cannabinoids (THC) | Ethyl Glucuronide | Fentanyl | Methamphetamine |
| Methadone | Opiate | PCP | Pregabalin |
| Synthetic Cannabinoids (UR-144) | Tricyclic Antidepressants | Tramadol | 6-MAM |
| ToxPlex MultiSTAT | |||
| Acetaminophen | Amphetamine | Barbiturates | Buprenorphine |
| Benzoylecgonine (BZG) | Cannabinoids (THC) | Clonazepam | Creatinine (Urine Only) |
| Dextromethorphan | Ethyl Glucuronide (EtG) | Fentanyl | Haloperidol |
| Ketamine | MDMA | Meprobamate | Methadone |
| Methamphetamine | Methaqualone | Opiate | Oxazepam |
| Oxycodone | Phencyclidine (PCP) | Pregabalin | Propoxyphene |
| Salicylate | Tramadol | Tricyclic Antidepressants (TCA) | Zolpidem |
| 6-MAM | Xylazine (Blood Only) |
| NPS I | |||
| AB-CHMINACA (Synthetic Cannabinoids) | AB-PINACA (Synthetic Cannabinoids) | Bath Salts I (Mephedrone / Methcathinone) | Bath Salts II (α-PVP / MDPV) |
| Benzylpiperazines | JWH-018 (Synthetic Cannabinoids) | Mescaline | Phenylpiperazines I |
| Phenylpiperazines II | Salvinorin | UR-144/XLR-11 (Synthetic Cannabinoids) | |
| NPS II | |||
| Acetylfentanyl | AH-7921 | Buprenorphine | Carfentanil/Remifentanil |
| Clonazepam | Etizolam | Furanylfentanyl | Mitragynine |
| MT-45 | Naloxone | Ocfentanyl | Sufentanil |
| U-47700 | W-19 |
